Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | -70.3% | -75.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -127.1% | 64.5% | 1.3% | 33.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $4 | $2 | $2 |
| SG&A Expenses | $1 | $4 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $4 | $2 | $2 |
| Operating Income | $0 | -$4 | -$2 | -$2 |
| % Margin | 7,661.5% | -35,147.7% | -5,699.6% | -1,187.3% |
| Other Income/Exp. Net | -$2 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$4 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$4 | -$1 | -$2 |
| % Margin | -77,714.6% | -36,323.8% | -3,173.6% | -1,353.5% |
| EPS | -3.18 | -3.35 | -1.7 | -3.63 |
| % Growth | 5.1% | -97.1% | 53.2% | – |
| EPS Diluted | -3.18 | -3.35 | -1.7 | -3.63 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$4 | -$1 | -$2 |
| % Margin | -2,031% | -35,739.3% | -1,815.4% | -1,067.6% |